Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


| Molecular Weight | 604.5 g/mol |
|---|---|
| Molecular Formula | C20H11N2Na3O10S3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 2 |
| Exact Mass | 603.92689092 g/mol |
| Monoisotopic Mass | 603.92689092 g/mol |
| Topological Polar Surface Area | 238 A^2 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 1190 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
47
PharmaCompass offers a list of New Coccine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right New Coccine manufacturer or New Coccine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred New Coccine manufacturer or New Coccine supplier.
PharmaCompass also assists you with knowing the New Coccine API Price utilized in the formulation of products. New Coccine API Price is not always fixed or binding as the New Coccine Price is obtained through a variety of data sources. The New Coccine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Brilliant Scarlet 4R manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brilliant Scarlet 4R, including repackagers and relabelers. The FDA regulates Brilliant Scarlet 4R manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brilliant Scarlet 4R API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Brilliant Scarlet 4R supplier is an individual or a company that provides Brilliant Scarlet 4R active pharmaceutical ingredient (API) or Brilliant Scarlet 4R finished formulations upon request. The Brilliant Scarlet 4R suppliers may include Brilliant Scarlet 4R API manufacturers, exporters, distributors and traders.
click here to find a list of Brilliant Scarlet 4R suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Brilliant Scarlet 4R DMF (Drug Master File) is a document detailing the whole manufacturing process of Brilliant Scarlet 4R active pharmaceutical ingredient (API) in detail. Different forms of Brilliant Scarlet 4R DMFs exist exist since differing nations have different regulations, such as Brilliant Scarlet 4R USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Brilliant Scarlet 4R DMF submitted to regulatory agencies in the US is known as a USDMF. Brilliant Scarlet 4R USDMF includes data on Brilliant Scarlet 4R's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Brilliant Scarlet 4R USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Brilliant Scarlet 4R suppliers with USDMF on PharmaCompass.
Brilliant Scarlet 4R Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brilliant Scarlet 4R GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brilliant Scarlet 4R GMP manufacturer or Brilliant Scarlet 4R GMP API supplier for your needs.
A Brilliant Scarlet 4R CoA (Certificate of Analysis) is a formal document that attests to Brilliant Scarlet 4R's compliance with Brilliant Scarlet 4R specifications and serves as a tool for batch-level quality control.
Brilliant Scarlet 4R CoA mostly includes findings from lab analyses of a specific batch. For each Brilliant Scarlet 4R CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brilliant Scarlet 4R may be tested according to a variety of international standards, such as European Pharmacopoeia (Brilliant Scarlet 4R EP), Brilliant Scarlet 4R JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brilliant Scarlet 4R USP).